Cargando…

Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion

BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous h...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigalionienė, Kristina, Burnytė, Birutė, Balkelienė, Danutė, Ambrozaitytė, Laima, Utkus, Algirdas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834195/
https://www.ncbi.nlm.nih.gov/pubmed/36181358
http://dx.doi.org/10.1002/mgg3.2059
_version_ 1784868408302501888
author Grigalionienė, Kristina
Burnytė, Birutė
Balkelienė, Danutė
Ambrozaitytė, Laima
Utkus, Algirdas
author_facet Grigalionienė, Kristina
Burnytė, Birutė
Balkelienė, Danutė
Ambrozaitytė, Laima
Utkus, Algirdas
author_sort Grigalionienė, Kristina
collection PubMed
description BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large‐scale mitochondrial DNA (mtDNA) deletions. Long‐range polymerase chain reaction (LR‐PCR), next generation sequencing (NGS) and multiplex ligation‐dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20‐year‐old male who presented with classic Kearns‐Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion. METHODS AND RESULTS: LR‐PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints. CONCLUSION: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods.
format Online
Article
Text
id pubmed-9834195
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98341952023-01-13 Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion Grigalionienė, Kristina Burnytė, Birutė Balkelienė, Danutė Ambrozaitytė, Laima Utkus, Algirdas Mol Genet Genomic Med Clinical Reports BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large‐scale mitochondrial DNA (mtDNA) deletions. Long‐range polymerase chain reaction (LR‐PCR), next generation sequencing (NGS) and multiplex ligation‐dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20‐year‐old male who presented with classic Kearns‐Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion. METHODS AND RESULTS: LR‐PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints. CONCLUSION: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods. John Wiley and Sons Inc. 2022-10-01 /pmc/articles/PMC9834195/ /pubmed/36181358 http://dx.doi.org/10.1002/mgg3.2059 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Clinical Reports
Grigalionienė, Kristina
Burnytė, Birutė
Balkelienė, Danutė
Ambrozaitytė, Laima
Utkus, Algirdas
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title_full Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title_fullStr Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title_full_unstemmed Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title_short Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
title_sort kearns‐sayre syndrome case. novel 5,9 kb mtdna deletion
topic Clinical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834195/
https://www.ncbi.nlm.nih.gov/pubmed/36181358
http://dx.doi.org/10.1002/mgg3.2059
work_keys_str_mv AT grigalionienekristina kearnssayresyndromecasenovel59kbmtdnadeletion
AT burnytebirute kearnssayresyndromecasenovel59kbmtdnadeletion
AT balkelienedanute kearnssayresyndromecasenovel59kbmtdnadeletion
AT ambrozaitytelaima kearnssayresyndromecasenovel59kbmtdnadeletion
AT utkusalgirdas kearnssayresyndromecasenovel59kbmtdnadeletion